mamaearth has incorporated a new wholly owned subsidiary, Honasa Health Private Limited, effective July 7, 2026. The Certificate of Incorporation was issued by the Ministry of Corporate Affairs and received by the company via email at 12:33 pm IST on the same day. This strategic expansion follows an earlier letter dated June 23, 2026, submitted to the exchanges.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that all necessary details regarding the new subsidiary, in line with the SEBI Master Circular dated January 30, 2026, were previously disclosed in its earlier intimation.

Key Details of the Incorporation

The filing was signed by Gaurav Pandit, Company Secretary and Compliance Officer of Honasa Consumer Limited. The information will be hosted on the company's official website, www.honasa.in . Honasa Consumer Limited is listed on both the National Stock Exchange of India and BSE Limited under the symbol HONASA.

mamaearth has secured a favorable rectification order in its arbitration proceedings against RSMM General Trading LLC, increasing the total monetary award to AED 9,918,514. The Arbitral Tribunal, via an order dated June 26, 2026, allowed the company's application under Section 33 of the Arbitration and Conciliation Act, 1996, to correct computational and clerical errors in the initial award passed on May 14, 2026. This development significantly enhances the financial relief granted to the company following breaches of the Authorized Distributor Agreement by RSMM.

The rectification order resulted in key adjustments to the awarded amounts. The damages for loss of profits were revised upward from AED 4.34 million to AED 7.32 million due to a computational error where the tribunal had inadvertently referred to figures for FY 2020-21 instead of FY 2021-22. Additionally, the costs awarded for substitution were corrected from AED 1,060,584 to AED 744,758 to align with the company's Statement of Claim. The tribunal also included a dispositive direction protecting the company against related court proceedings in Dubai.

Final Amended Award Details

Pursuant to the Section 33 Order, the final amended directives against RSMM include a total monetary payout of AED 9,918,514, approximately INR 25,53,55,217.67. The tribunal directed that post-award interest will apply if the amount remains unpaid for more than 30 days. RSMM is also liable to pay the company damages equivalent to any financial recoveries made against it in related Dubai court proceedings, including the judgment dated February 11, 2026, or any appeals arising from it.

The breakdown of the awarded amounts includes AED 1,559,848 for costs incurred by the company for proceedings in Dubai and allied proceedings in India, and AED 744,758 towards costs of substitution. The award also comprises INR 76,50,875 towards the costs of arbitration proceedings. The interest penalty is set at EIBOR + 2% per annum on the AED components and at the SBI Prime Lending Rate (PLR) + 2% per annum on the INR component, calculated from 30 days after the pronouncement of the award until payment.

The tribunal further issued a permanent prohibitory injunction restraining RSMM from initiating or continuing any proceedings before courts in Dubai or any other forum that breach the dispute resolution and exclusive jurisdiction clauses of the Authorized Distributor Agreement. The order confirms that proceedings initiated in Dubai by RSMM are in breach of the arbitration agreement and the governing law clause.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE0J5401028/03928f83164c4f40.pdf